Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 276

1.

Iron deficiency across chronic inflammatory conditions: International expert opinion on definition, diagnosis, and management.

Cappellini MD, Comin-Colet J, de Francisco A, Dignass A, Doehner W, S P Lam C, Macdougall IC, Rogler G, Camaschella C, Kadir R, Kassebaum NJ, Spahn DR, Taher AT, Musallam KM; IRON CORE Group.

Am J Hematol. 2017 Oct;92(10):1068-1078. doi: 10.1002/ajh.24820. Epub 2017 Jul 7. Review.

2.

Association between recurrence of acute kidney injury and mortality in intensive care unit patients with severe sepsis.

Rodrigo E, Suberviola B, Santibáñez M, Belmar L, Castellanos Á, Heras M, Rodríguez-Borregán JC, de Francisco ALM, Ronco C.

J Intensive Care. 2017 May 22;5:28. doi: 10.1186/s40560-017-0225-0. eCollection 2017.

3.

Safety of intravenous ferric carboxymaltose versus oral iron in patients with nondialysis-dependent CKD: an analysis of the 1-year FIND-CKD trial.

Roger SD, Gaillard CA, Bock AH, Carrera F, Eckardt KU, Van Wyck DB, Cronin M, Meier Y, Larroque S, Macdougall IC; FIND-CKD Study Investigators.

Nephrol Dial Transplant. 2017 Sep 1;32(9):1530-1539. doi: 10.1093/ndt/gfw264.

PMID:
28339831
4.

Renal function in patients with non-dialysis chronic kidney disease receiving intravenous ferric carboxymaltose: an analysis of the randomized FIND-CKD trial.

Macdougall IC, Bock AH, Carrera F, Eckardt KU, Gaillard C, Van Wyck D, Meier Y, Larroque S, Roger SD; FIND-CKD Study investigators.

BMC Nephrol. 2017 Jan 17;18(1):24. doi: 10.1186/s12882-017-0444-6.

5.

New oral anticoagulants in patients with chronic kidney disease.

Belmar Vega L, de Francisco ALM, Bada da Silva J, Galván Espinoza L, Fernández Fresnedo G.

Nefrologia. 2017 May - Jun;37(3):244-252. doi: 10.1016/j.nefro.2016.08.006. Epub 2016 Dec 9. English, Spanish.

6.

Life cycle assessment of medium-density fiberboard (MDF) manufacturing process in Brazil.

Piekarski CM, de Francisco AC, da Luz LM, Kovaleski JL, Silva DA.

Sci Total Environ. 2017 Jan 1;575:103-111. doi: 10.1016/j.scitotenv.2016.10.007. Epub 2016 Oct 10.

PMID:
27736694
7.

Using multistakeholder dialogues to assess policies, programmes and progress for women's, children's and adolescents' health.

Frost L, Hinton R, Pratt BA, Murray J, Arscott-Mills S, Jack S, de Francisco A, Kuruvilla S.

Bull World Health Organ. 2016 May 1;94(5):393-5. doi: 10.2471/BLT.16.171710. Epub 2016 May 2. No abstract available.

8.

Investigation of iron deficiency in patients with congestive heart failure: A medical practice that requires greater attention.

Belmar Vega L, de Francisco A, Albines Fiestas Z, Serrano Soto M, Kislikova M, Seras Mozas M, Unzueta MG, Arias Rodríguez M.

Nefrologia. 2016 May-Jun;36(3):249-54. doi: 10.1016/j.nefro.2016.03.001. Epub 2016 Apr 4. English, Spanish.

9.

Systematic review on human resources for health interventions to improve maternal health outcomes: evidence from low- and middle-income countries.

Lassi ZS, Musavi NB, Maliqi B, Mansoor N, de Francisco A, Toure K, Bhutta ZA.

Hum Resour Health. 2016 Mar 12;14:10. doi: 10.1186/s12960-016-0106-y. Review.

10.

Iron management in chronic kidney disease: conclusions from a "Kidney Disease: Improving Global Outcomes" (KDIGO) Controversies Conference.

Macdougall IC, Bircher AJ, Eckardt KU, Obrador GT, Pollock CA, Stenvinkel P, Swinkels DW, Wanner C, Weiss G, Chertow GM; Conference Participants.

Kidney Int. 2016 Jan;89(1):28-39. doi: 10.1016/j.kint.2015.10.002.

11.

Anti-parathyroid treatment effectiveness and persistence in incident haemodialysis patients with secondary hyperparathyroidism.

de Francisco AL, Gillespie IA, Gioni I, Floege J, Kronenberg F, Marcelli D, Wheeler DC, Froissart M, Drueke TB; ARO Steering Committee Cllaborators.

Nefrologia. 2016;36(2):164-75. doi: 10.1016/j.nefro.2015.10.006. Epub 2015 Dec 3.

12.

Countdown to 2015: a decade of tracking progress for maternal, newborn, and child survival.

Victora CG, Requejo JH, Barros AJ, Berman P, Bhutta Z, Boerma T, Chopra M, de Francisco A, Daelmans B, Hazel E, Lawn J, Maliqi B, Newby H, Bryce J.

Lancet. 2016 May 14;387(10032):2049-59. doi: 10.1016/S0140-6736(15)00519-X. Epub 2015 Oct 22. Review. Erratum in: Lancet. 2016 May 14;387(10032):1998.

PMID:
26477328
13.

Long-Term Mortality among Hospitalized Non-ICU Patients with Acute Kidney Injury Referred to Nephrology.

Ruiz-Criado J, Ramos-Barron MA, Fernandez-Fresnedo G, Rodrigo E, De Francisco AL, Arias M, Gomez-Alamillo C.

Nephron. 2015;131(1):23-33. doi: 10.1159/000437340. Epub 2015 Aug 12.

PMID:
26277844
14.

Methodology used in studies reporting chronic kidney disease prevalence: a systematic literature review.

Brück K, Jager KJ, Dounousi E, Kainz A, Nitsch D, Ärnlöv J, Rothenbacher D, Browne G, Capuano V, Ferraro PM, Ferrieres J, Gambaro G, Guessous I, Hallan S, Kastarinen M, Navis G, Gonzalez AO, Palmieri L, Romundstad S, Spoto B, Stengel B, Tomson C, Tripepi G, Völzke H, Wiȩcek A, Gansevoort R, Schöttker B, Wanner C, Vinhas J, Zoccali C, Van Biesen W, Stel VS; European CKD Burden Consortium.

Nephrol Dial Transplant. 2015 Aug;30 Suppl 4:iv6-16. doi: 10.1093/ndt/gfv131. Review.

15.

Propensity score matching and persistence correction to reduce bias in comparative effectiveness: the effect of cinacalcet use on all-cause mortality.

Gillespie IA, Floege J, Gioni I, Drüeke TB, de Francisco AL, Anker SD, Kubo Y, Wheeler DC, Froissart M; on behalf the ARO Steering Committee collaborators.

Pharmacoepidemiol Drug Saf. 2015 Jul;24(7):738-47. doi: 10.1002/pds.3789. Epub 2015 May 26.

16.

High cardiovascular event rates occur within the first weeks of starting hemodialysis.

Eckardt KU, Gillespie IA, Kronenberg F, Richards S, Stenvinkel P, Anker SD, Wheeler DC, de Francisco AL, Marcelli D, Froissart M, Floege J; ARO Steering Committee.

Kidney Int. 2015 Nov;88(5):1117-25. doi: 10.1038/ki.2015.117. Epub 2015 Apr 29.

17.

Post return of spontaneous circulation factors associated with mortality in pediatric in-hospital cardiac arrest: a prospective multicenter multinational observational study.

López-Herce J, del Castillo J, Matamoros M, Canadas S, Rodriguez-Calvo A, Cecchetti C, Rodríguez-Núnez A, Carrillo Á; Iberoamerican Pediatric Cardiac Arrest Study Network RIBEPCI.

Crit Care. 2014 Nov 3;18(6):607. doi: 10.1186/s13054-014-0607-9.

18.

Mortality and cardiovascular morbidity associated with haemoglobin levels: a pooled analysis of randomised controlled trials.

Locatelli F, de Francisco A, Deray G, Fliser D, Armstrong G, Dougherty FC, Ehrhard P.

Nephron Clin Pract. 2014;128(3-4):323-32. doi: 10.1159/000366478. Epub 2014 Dec 5.

19.

Effect of calcium acetate/magnesium carbonate in the treatment of hyperphosphataemia in dialysis patients in real clinical practice. One year follow up.

de Francisco AL, Belmar L, Piñera C, Kislikova M, Seras M, Serrano M, Albines Z, Sango C, Arias M.

Nefrologia. 2014;34(5):617-27. doi: 10.3265/Nefrologia.pre2014.Jul.12527. English, Spanish.

20.

Incidence of erythropoietin antibody-mediated pure red cell aplasia: the Prospective Immunogenicity Surveillance Registry (PRIMS).

Macdougall IC, Casadevall N, Locatelli F, Combe C, London GM, Di Paolo S, Kribben A, Fliser D, Messner H, McNeil J, Stevens P, Santoro A, De Francisco AL, Percheson P, Potamianou A, Foucher A, Fife D, Mérit V, Vercammen E; PRIMS study group.

Nephrol Dial Transplant. 2015 Mar;30(3):451-60. doi: 10.1093/ndt/gfu297. Epub 2014 Sep 19.

Supplemental Content

Loading ...
Support Center